Evidence map›Paper›PMID 21900013›Full record

ArticleBioorganic & medicinal chemistry2011

New aporphinoid 5-HT2A and α1A antagonists via structural manipulations of nantenine.

Sandeep Chaudhary, Shashikanth Ponnala, Onica Legendre, Junior A Gonzales, Hernán A Navarro, Wayne W Harding

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.Bioorganic & medicinal chemistry letters · 2015
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sandeep ChaudharyDepartment of Chemistry, Hunter College, CUNY, New York, NY 10065, USA.
Shashikanth Ponnala
Onica Legendre
Junior A Gonzales
Hernán A Navarro
Wayne W Harding
Hunter College · USRTI International · US

Funding

WILD TYPE &MUTANT P53 INTERACTIONS WITH HIV LTR DNAG12RR003037 · NCRR · HUNTER COLLEGE · PI DOTTIN, ROBERT P · 1985 to 2011
$27.6M
Synthesis and Evaluation of Aporphines as MDMA Antagonists.R03DA025910 · NIDA · HUNTER COLLEGE · PI HARDING, WAYNE WESLEY · 2009 to 2010
$407k
NCRR NIH HHS G12 RR003037NCRR NIH HHS RR03037NIDA NIH HHS R03 DA025910NIDA NIH HHS R03DA025910
6 · The paper itself

Abstract

A series of C1, C2, C3 and N6 analogs of nantenine (2) was synthesized and evaluated in 5-HT(2A) and α(1A) receptor functional assays. Alkyl substitution of the C1 and N6 methyl groups of nantenine provided selective 5-HT(2A) and α(1A) antagonists, respectively. The C2 alkyloxy analogs studied were generally selective for α(1A) versus 5-HT(2A). The C3 bromo analog 15 is one of the most potent aporphinoid 5-HT(2A) antagonists known presently.

Indexed as

Adrenergic alpha-1 Receptor AntagonistsAporphinesReceptors, Adrenergic, alpha-1Receptor, Serotonin, 5-HT2ASerotonin 5-HT2 Receptor AntagonistsStructure-Activity Relationship3-bromonantenineAdrenergic alpha-1 Receptor AntagonistsAporphinesnantenineReceptors, Adrenergic, alpha-1Receptor, Serotonin, 5-HT2ASerotonin 5-HT2 Receptor Antagonists

Identifiers

PMID21900013
PMCPMC3196372
OpenAlexW2075355393

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.